HomeIPHA • NASDAQ
Innate Pharma SA
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.43M | -60.63% |
Operating expense | 4.88M | 1.93% |
Net income | -10.67M | 13.81% |
Net profit margin | -439.18 | -118.93% |
Earnings per share | — | — |
EBITDA | -12.53M | 1.97% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.03M | -34.61% |
Total assets | 92.94M | -38.65% |
Total liabilities | 87.79M | -28.45% |
Total equity | 5.14M | — |
Shares outstanding | 92.16M | — |
Price to book | 32.50 | — |
Return on assets | -34.20% | — |
Return on capital | -98.79% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -10.67M | 13.81% |
Cash from operations | -15.58M | -1,126.48% |
Cash from investing | 3.49M | 648.28% |
Cash from financing | 5.24M | 342.11% |
Net change in cash | -6.35M | -1,960.39% |
Free cash flow | -6.92M | 1.68% |
Previous close
$1.95
Day range
$1.97 - $2.01
Year range
$1.29 - $3.51
Market cap
192.43M USD
Avg Volume
17.45K
P/E ratio
-
Dividend yield
-
About
Founded
1999
Website
Employees
174
